Abstract
The staining patterns obtained with two antibodies against proliferating cell nuclear antigen (PC10 and 19A2) and another cell cycle associated antibody (KiS1) were compared with each other and with a number of established prognostic markers of breast carcinoma. Although PC10 and 19A2 staining patterns were similar, only the latter was significantly associated with KiS1 antibody staining. These findings suggest that the two PCNA antibodies detect different epitopes. KiS1 was the only antibody to show an association with S phase fraction measured by flow cytometry (p < 0.001). It was also associated with histological grade (p = 0.003), oestrogen receptors (p = 0.045), and DNA index (p = 0.007). PC10 showed no association with any of the markers of prognosis, while 19A2 was associated with histological grade (p = 0.017) and oestrogen receptors (p = 0.043). The two PCNA antibodies do not seem to be of value in measuring proliferative activity nor do they seem to be associated with established markers of prognosis in breast cancer.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Battersby S., Anderson T. J. Correlation of proliferative activity in breast tissue using PCNA/cyclin. Hum Pathol. 1990 Jul;21(7):781–781. doi: 10.1016/0046-8177(90)90039-8. [DOI] [PubMed] [Google Scholar]
- Camplejohn R. S., Brock A., Barnes D. M., Gillett C., Raikundalia B., Kreipe H., Parwaresch M. R. Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells. Br J Cancer. 1993 Apr;67(4):657–662. doi: 10.1038/bjc.1993.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gasparini G., Meli S., Pozza F., Cazzavillan S., Bevilacqua P. PC-10 antibody to proliferating cell nuclear antigen (PCNA) is not related to prognosis in human breast carcinoma. Growth Regul. 1992 Dec;2(4):145–150. [PubMed] [Google Scholar]
- Jain S., Filipe M. I., Hall P. A., Waseem N., Lane D. P., Levison D. A. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol. 1991 Aug;44(8):655–659. doi: 10.1136/jcp.44.8.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leonardi E., Girlando S., Serio G., Mauri F. A., Perrone G., Scampini S., Dalla Palma P., Barbareschi M. PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables. J Clin Pathol. 1992 May;45(5):416–419. doi: 10.1136/jcp.45.5.416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sampson S. A., Kreipe H., Gillett C. E., Smith P., Chaudary M. A., Khan A., Wicks K., Parwaresch R., Barnes D. M. KiS1--a novel monoclonal antibody which recognizes proliferating cells: evaluation of its relationship to prognosis in mammary carcinoma. J Pathol. 1992 Oct;168(2):179–185. doi: 10.1002/path.1711680205. [DOI] [PubMed] [Google Scholar]
- Wilson G. D., Camplejohn R. S., Martindale C. A., Brock A., Lane D. P., Barnes D. M. Flow cytometric characterisation of proliferating cell nuclear antigen using the monoclonal antibody PC10. Eur J Cancer. 1992;28A(12):2010–2017. doi: 10.1016/0959-8049(92)90250-6. [DOI] [PubMed] [Google Scholar]
- Woods A. L., Hall P. A., Shepherd N. A., Hanby A. M., Waseem N. H., Lane D. P., Levison D. A. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology. 1991 Jul;19(1):21–27. doi: 10.1111/j.1365-2559.1991.tb00890.x. [DOI] [PubMed] [Google Scholar]
- Yu C. C., Fletcher C. D., Newman P. L., Goodlad J. R., Burton J. C., Levison D. A. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours. J Pathol. 1992 Feb;166(2):147–152. doi: 10.1002/path.1711660210. [DOI] [PubMed] [Google Scholar]